Handling Hazardous Drugs

Type of Activity / Target Audience

This knowledge-based activity is designed for those working in a healthcare setting that is handling hazardous drugs to educate on risks of exposure, prevention strategies and workflow.

Statement of Need
Pharmacists and technicians need to have an understanding of how to properly handle hazardous drugs to prevent exposure to themselves, patients and other healthcare workers.

Learning Objectives:

At the conclusion of this activity Pharmacists should be able to:

1. Discuss 3 activities where pharmacy healthcare workers handle HDs and the potential route of exposure for each
2. Explain what supplemental control needs to be used during the administration of antineoplastic HDs with the appropriate dosage form
3. Discuss 8 activities noted in USP 800 where PPE is required
4. Discuss what must be available, according to USP Chapter <800>, in all areas where hazardous drugs are handled
5. List 7 topics for training the designated person is responsible for ensuring all personnel are compliant with

At the conclusion of this activity, Technicians should be able to:

1. List 4 potential routes of exposure when handling hazardous drugs
2. Explain what types of HDs need to be stored separately inside a negative pressure environment
3. Explain how often gowns need to be changed during continuous use in compounding with HDs
4. Discuss the 3 PPE components that must be used when disposing of HDs
5. List the 4 steps for properly cleaning up a hazardous drug spill

Faculty
Seth DePasquale, R.Ph., BCSCP

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Lyceum are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity. 

I do not have any relevant financial / non-financial relationships with any proprietary interests

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses. 
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.